- Investing Ideas
- /
- Dutch Strong Balance Sheet Stocks
Dutch Strong Balance Sheet Stocks
UPDATED May 02, 2024
Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.
68 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
EAS2P | €0.56 | -2.8% | -12.5% | €13.2m | n/a | PS4.9x | n/a | 0% | Software | ||
HEIJM | €17.42 | -0.1% | 56.4% | €467.3m | €17.75 | PE7.8x | E10.2% | 5.1% | Capital Goods | ||
BBED | €5.98 | 0.3% | 111.3% | €164.7m | €6.10 | PE21.5x | E15.3% | 2.5% | Retail | ||
ECT | €7.30 | -2.0% | 12.3% | €7.3m | n/a | PS15.4x | n/a | 0% | Real Estate Management and Development | ||
BEVER | €2.46 | 0% | -27.6% | €42.0m | n/a | PS39.2x | n/a | n/a | Real Estate Management and Development | ||
BESI | €120.40 | -11.5% | 43.0% | €9.3b | €149.26 | PE52.5x | E26.5% | 1.8% | Semiconductors | ||
HAL | €119.60 | -4.2% | -5.1% | €10.8b | €140.67 | PE10.8x | E4.1% | 2.4% | Diversified Financials | ||
SIFG | €10.14 | 0% | -16.3% | €303.1m | €13.33 | PE33.8x | E50.1% | 0% | Capital Goods | ||
TOM2 | €5.62 | -2.8% | -25.1% | €717.4m | €9.13 | PS1.2x | E95.3% | n/a | Software | ||
GLPG | €27.34 | 2.5% | -29.2% | €1.8b | €37.93 | PS7.5x | E-31.8% | n/a | Pharmaceuticals & Biotech | ||
ADYEN | €1,128.80 | -4.3% | -21.3% | €35.0b | €1,626.23 | PE50.2x | E19.3% | n/a | Diversified Financials | ||
RAND | €46.52 | 0.2% | -2.9% | €8.2b | €48.93 | PE15x | E13.1% | 4.9% | Commercial Services | ||
HOLCO | €97.00 | 1.0% | -20.5% | €83.5m | n/a | PE20.7x | n/a | 3.5% | Materials | ||
MT | €24.33 | 2.4% | -1.2% | €19.9b | €31.88 | PE28.1x | E42.0% | 1.9% | Materials | ||
BAI | €0.64 | -1.5% | -67.5% | €78.0m | €1.90 | PS9.1x | E49.1% | n/a | Pharmaceuticals & Biotech | ||
VVY | €0.71 | -13.4% | -95.7% | €18.5m | €41.57 | PB0.7x | E73.4% | n/a | Pharmaceuticals & Biotech | ||
PHARM | €0.90 | -0.2% | -16.4% | €604.7m | €2.00 | PS2.6x | E53.0% | n/a | Pharmaceuticals & Biotech | ||
IRIS | US$10.00 | 0% | n/a | US$57.5m | n/a | PE114x | n/a | n/a | Diversified Financials | ||
NEDAP | €62.00 | -0.6% | 6.9% | €406.3m | €63.00 | PE18.8x | E15.2% | 5.2% | Tech | ||
FUR | €22.78 | -2.6% | 71.5% | €2.6b | €29.02 | PE10.2x | E5.7% | 1.8% | Capital Goods | ||
PBH | €2.78 | -6.1% | -7.9% | €15.8m | n/a | PB0.9x | n/a | 0% | Retail | ||
AALB | €44.50 | 0% | 5.7% | €4.9b | €52.14 | PE15.6x | E7.2% | 2.5% | Capital Goods | ||
HYDRA | €142.00 | 0% | 56.0% | €184.2m | n/a | PE11.7x | n/a | 0% | Materials | ||
EHCS | €9.15 | 0% | -7.6% | €183.0m | n/a | PE6.9x | n/a | n/a | Diversified Financials |